Ethex Corporation has issued a voluntary recall oncertain products, expanding it to the retail level. The company is taking thisaction as a precautionary measure because the products may have beenmanufactured under conditions that did not sufficiently comply with current GoodManufacturing Practice (cGMP).

The expanded recall includes the followingproducts: 

-Morphine sulfate extended-release tablets 15mg, 30mgand 60mg
-Morphine sulfate immediate-release tablets 15mg and30mg
-Dextroamphetamine sulfate tablets 5mg and10mg
-Isosorbide mononitrate extended-release tablets 30mg,60mg and 120mg
-Propafenone HCl tablets 150mg, 225mg and 300mg.

For more information call (800) 748-1472 or visit www.kvpharmaceutical.com.